Analysis | Metabolite Name | Measured Value | Units | Construct |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | ALANINE (CAS# 56-41-7); (M-H)- | 13252 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | ALANINE (CAS# 56-41-7); (M-H)- | 14202 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | ALANINE (CAS# 56-41-7); (M-H)- | 14356 | Peak area | Control lentivirus |
Reversed phase NEGATIVE ION MODE | ALANINE (CAS# 56-41-7); (M-H)- | 15509 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | ALANINE (CAS# 56-41-7); (M-H)- | 16974 | Peak area | Noxa knockdown |
Reversed phase NEGATIVE ION MODE | ALANINE (CAS# 56-41-7); (M-H)- | 17071 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (2M+H)+[-H2O] | 18725 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (2M+H)+[-H2O] | 32032 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (2M+H)+[-H2O] | 35302 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (2M+H)+[-H2O] | 37991 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (2M+H)+[-H2O] | Peak area | Control lentivirus | |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (M+H)+ | 5021 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (M+H)+ | 7974 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (M+H)+ | 15142 | Peak area | Control lentivirus |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (M+H)+ | 37505 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (M+H)+ | 38377 | Peak area | Noxa knockdown |
Reversed phase POSITIVE ION MODE | ALANINE (CAS# 56-41-7); (M+H)+ | Peak area | Control lentivirus |